↓ Skip to main content

Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial

Overview of attention for article published in Clinical Drug Investigation, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
97 Mendeley
Title
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial
Published in
Clinical Drug Investigation, January 2020
DOI 10.1007/s40261-019-00882-6
Pubmed ID
Authors

Ebrahim Salehifar, Ghasem Janbabaei, Narjes Hendouei, Abbas Alipour, Nasim Tabrizi, Razieh Avan

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 97 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 9%
Student > Master 9 9%
Student > Bachelor 7 7%
Student > Ph. D. Student 6 6%
Other 5 5%
Other 22 23%
Unknown 39 40%
Readers by discipline Count As %
Medicine and Dentistry 22 23%
Nursing and Health Professions 12 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Unspecified 6 6%
Psychology 3 3%
Other 5 5%
Unknown 43 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2021.
All research outputs
#4,650,946
of 25,711,518 outputs
Outputs from Clinical Drug Investigation
#137
of 1,041 outputs
Outputs of similar age
#102,803
of 479,480 outputs
Outputs of similar age from Clinical Drug Investigation
#3
of 8 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,041 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.